Skip to main content
Top

Indian Journal of Hematology and Blood Transfusion

Issue 1/2017

Content (30 Articles)

Review Article

The Laboratory Diagnosis of the Antiphospholipid Syndrome

Jasmina Ahluwalia, Sreejesh Sreedharanunni

Review Article

Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

Uday Yanamandra, Navin Khattry, Shaji Kumar, Noopur Raje, Arihant Jain, Sundar Jagannath, Hari Menon, Lalit Kumar, Neelam Varma, Subhash Varma, Tapan Saikia, Pankaj Malhotra, Abhay Bhave, Ajay Sharma, A. K. Tripathi, Alka Khadwal, Anil Aribandi, Anita Ramesh, Ashish Dixit, Anup J. Devasia, Charu Batra, Chezhian Subash, Dharma Choudhary, Dinesh Bhurani, Deepesh Lad, Farah Jijina, Gaurav Prakash, Ganesh Jaishetwar, Harshit Khurana, Hemant Malhotra, H. S. Kohli, Ian Pinto, Javid Rasool, Jatin Sarin, Jina Bhattacharyya, Col Jasjit Singh, K. Govind Babu, K. Pavithran, Kannan Subramanian, M. Joseph John, Man Updesh Singh Sachdeva, Maitreyee Bhattacharyya, M. B. Agarwal, Manju Sengar, Narender Kumar, Nitin Sood, Prantar Chakravarti, P. G. Subramanian, Prashant Sharma, Prashant Tembhare, Pravas Mishra, Prasanth Ganesan, Rahul Naithani, Rayaz Ahmed, Ritu Gupta, Ritu Bansal, R. Itambhra Nada, Raman Arora, Rajan Kapoor, Reena Das, Reena Nair, Sandeep Shah, Savita Kumari, Sharat Damodar, Sachin Gupta, Sameer Melinkeri, Shano Naseem, Sreejesh Sreedharanunni, Suparno Chakrabarti, Sadashivudu Gundeti, S. R. Das, Soniya Nityanand, Seema Bhatwadekar, Shankar Prinja, Tejinder Singh, Vikas Suri, Velu Nair

Original Article

Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India

Shankar Prinja, Gunjeet Kaur, Pankaj Malhotra, Gaurav Jyani, Raja Ramachandran, Pankaj Bahuguna, Subhash Varma

Original Article

Tumor Lysis Syndrome in Multiple Myeloma: An Increasingly Recognized Risk—A Report of Seven Cases

Abhijai Singh, Shweta Gupta, Barbara Yim, Romy Thekkekara

Original Article

Treatment of Acute Promyelocytic Leukemia with Single Agent Arsenic Trioxide: Experience from a Tertiary Care Center in India

Karthik Udupa, Joseph Thomas, Chethana Babu Udupa, V. S. Binu, Prahlad Sharan

Original Article

Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype

Dalia Salem, Sherin Abd El-Aziz, Nadia El-Menshawy, Tarek Abouzeid, Mohamed Ebrahim

Original Article

Clinical Characteristics and Prognosis of 167 Cases of Acute Erythroleukemia

Zhi-qiang Ma, Ji-hong Pan, Da-xin Jing, Chong-yan Xu

Original Article

L-PROBe: A Novel Non-anthracycline Combination Chemotherapy Regimen for Aggressive B Cell Non-Hodgkin Lymphoma in Elderly Patients

Arjun Datt Law, Gaurav Prakash, Alka Khadwal, Ashim Das, Subhash Varma, Pankaj Malhotra

Original Article

NK/T Cell Lymphoma: A Tertiary Centre Experience

Neeraj Arora, Arpan Mehta, Sriram Ravichandran, Indu Arun, Rimpa Basu Achari, Anupam Chakrapani, Saurabh Jayant Bhave, Mammen Chandy, Reena Nair

Original Article

Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib

Sandip Ganguly, K. C. Lakshmaiah, Linu Abraham Jacob, Suresh Babu, Lokanatha Dasappa, K. S. Govind Babu

Original Article

Performance of Galactomannan Antigen, Beta-d-Glucan, and Aspergillus-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis

Gökhan Metan, Muzaffer Keklik, Gökçen Dinç, Çiğdem Pala, Afra Yıldırım, Berkay Saraymen, Mustafa Yavuz Köker, Leylagül Kaynar, Bülent Eser, Mustafa Çetin

Original Article

Initial Lymphocyte Count as Prognostic Indicator for Childhood Immune Thrombocytopenia

Sinan Akbayram, Kamuran Karaman, Murat Dogan, Lokman Ustyol, Mesut Garipardic, Ahmet Faik Oner

Original Article

Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases

Anil Tombak, Mehmet Ali Uçar, Aydan Akdeniz, Arda Yilmaz, Hakan Kaleagası, Mehmet Ali Sungur, Eyup Naci Tiftik

Short Communication

Adverse Events During Apheresis Procedures: Audit at a Tertiary Hospital

Kanchan Dogra, Parag Fulzele, Diptiranjan Rout, Rahul Chaurasia, Poonam Coshic, Kabita Chatterjee

Original Article

Nanostructural Changes in the Cell Membrane of Gamma-Irradiated Red Blood Cells

Khalid AlZahrani, Hamed A. Al-Sewaidan

Original Article

Evaluation of the Sensitivity and Specificity of Use of Glucose and pH for Bacterial Screening of Platelet Concentrates Compared to the Bact/Alert

Farhad Razjou, Hossein Timori Naghadeh, Shirin Ferdowsi, Abolfazl Dabirmoghadam

Images

Multiple Auer Rod Like Inclusions in Multiple Myeloma

Narender Tejwani, Seema Tyagi, Jasmita Dass

Images

Coexistent Multiple Myeloma and SLL: A Rare Entity

Parul Tanwar, Sonal Jain, Anurag Mehta, Dinesh Bhurani, Narendra Agrawal, Rayaz Ahmed

Images

Intriguing Morphology of IgG/Lambda Secreting Myeloma Cells

Sreejesh Sreedharanunni, Narender Kumar, Neelam Varma

Images

Plasma Cell Leukemia Presenting with Hyperleukocytosis and Anaplasia

Pulkit Rastogi, Jasmina Ahluwalia, Kanagaraja Karunakaran Parathan, Pankaj Malhotra

Correspondence

Priapism as the Presenting Manifestation of Multiple Myeloma

Kamal Kant Sahu, Kundan Mishra, Deba Prasad Dhibar, Tulasi Ram, Ganesh Kumar, Sanjay Jain, Shano Naseem, Pankaj Malhotra

Correspondence

Multiple Myeloma: A Rare Haematological Cause of Nasal Septal Perforation and a Vasculitis Mimic

Ankur Jain, Prasanth Balasubramaniam, Ram V. Nampoothiri, Pankaj Malhotra, Alka Khadwal, Gaurav Prakash, Kim Vaiphai, Subhash Varma

Correspondence

Outcome of Cyclosporine Monotherapy in Patients of Aplastic Anemia: Experience of a Tertiary Care Hospital in Eastern India

Prakas Kumar Mandal, Suvraneel Baul, Tuphan Kanti Dolai, Rajib De, Prantar Chakrabarti

Correspondence

Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis

Rajat Thawani, Shishir Seth, Kuldeep Singh, Jayanta Patowary, Mano Bhadauria, Pratap Kishore Das

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine